Radioprotectors in treatment therapy to reduce risk in secondary tumor induction.
Grdina
D J
DJ
Argonne National Laboratory, IL 60439-4833.
Nagy
B
B
Sigdestad
C P
CP
D004999:Amifostine / Q000627:therapeutic use; D000818:Animals; D002471:Cell Transformation, Neoplastic / Q000187:drug effects / Q000528:radiation effects; D006801:Humans; D008624:Mercaptoethylamines / Q000627:therapeutic use; D009369:Neoplasms / Q000532:radiotherapy*; D009381:Neoplasms, Radiation-Induced / Q000517:prevention & control*; D011837:Radiation-Protective Agents / Q000627:therapeutic use*
D008624:Mercaptoethylamines; D011837:Radiation-Protective Agents; C020174:N-(2-mercaptoethyl)-1,3-diaminopropane; D004999:Amifostine